Latest revenue
$35.5M
as of 2026-03-31
Latest net income
$-4.3M
as of 2026-03-31
Net margin
-12.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $16.0M
- Enterprise value
- $16.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $4.96
- 52-wk low
- $2.33
- Beta
- —
- Shares out
- 6.3M
5-year trend
What this company does
ITEM 1. BUSINESS General Our vision is to enrich the world through the best of nutrition. We are a leading formulator, manufacturer and marketer of nutritional supplements. Our comprehensive strategic partnerships with our customers allow us to offer a wide range of innovative nutritional products and services to such customers including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. As our primary business activity, we provide private-label contract…
AI summary unavailable — showing raw filing excerpt
Generated from NAII's filing dated 2025-09-23
Key risks
ITEM 1A. RISK FACTORS When evaluating our business and future prospects, you should carefully review and consider the risks described below in conjunction with other information in this report and in other reports and documents we file with the SEC. The risks and uncertainties described below are not the only ones we face. Additional material risks and uncertainties, not presently known to us, or that we currently see as immaterial, may also occur or become material. If any of the following risks or any additional risks and uncertainties actually occur or become material, our business, financial condition and results of operations could be seriously harmed. In that event, the market price…
AI summary unavailable — showing raw filing excerpt
Generated from NAII's filing dated 2025-09-23
Profitability
Gross margin
7.2%
18.6%Operating margin
-6.7%
11.1%Net margin
-10.5%
64.8%Return on equity
-19.8%
127.0%Return on assets
-8.9%
101.0%Leverage
Debt / equity
1.22×
26.4%Long-term debt / equity
0.13×
16.6%Debt / assets
55.0%
11.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $35.5M | +23.3% | $-4.3M | -97.2% | -12.1% |
Q4 2025 2025-12-31 | $34.8M | +2.1% | $-2.6M | -16.5% | -7.3% |
Q3 2025 2025-09-30 | $37.7M | +13.8% | $-291.0K | +85.3% | -0.8% |
Q2 2025 2025-06-30 | $33.9M | +14.8% | $-7.2M | -285.1% | -21.3% |
Q1 2025 2025-03-31 | $28.8M | +14.4% | $-2.2M | -38.5% | -7.6% |
Q4 2024 2024-12-31 | $34.1M | +35.2% | $-2.2M | +28.6% | -6.4% |
Q3 2024 2024-09-30 | $33.1M | -2.4% | $-2.0M | -185.2% | -6.0% |
Q2 2024 2024-06-30 | $29.5M | — | $-1.9M | — | -6.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Medicinal Chemicals & Botanical Products · SIC 2833
Your notes
Keep private notes on NAII — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$26.8K
Insider selling
$0
Net activity
+$26.8K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns NAII
Institutional value
$3.7M
Total shares held
1.4M
Distinct holders
10
-13 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | CALDWELL SUTTER CAPITAL, INC. | 498.8K | $1.3M | +37.0K (+8.0%) | Added |
| 2 | DIMENSIONAL FUND ADVISORS LP | 354.7K | $933.0K | -29.8K (-7.7%) | Trimmed |
| 3 | Mink Brook Asset Management LLC | 293.7K | $772.5K | +0 (+0.0%) | No change |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 210.9K | $554.6K | — | New |
| 5 | VANGUARD FIDUCIARY TRUST CO | 27.1K | $71.3K | — | New |
| 6 | JAMES INVESTMENT RESEARCH, INC. | 10.0K | $26.4K | +0 (+0.0%) | No change |
| 7 | Vanguard Global Advisers, LLC | 2.8K | $7.4K | — | New |
| 8 | CITIGROUP INC | 2.0K | $5.2K | +2.0K (+199000.0%) | Added |
| 9 | GILL CAPITAL PARTNERS, LLC | 7 | $18 | — | New |
| 10 | SBI Securities Co., Ltd. | 5 | $13 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once NAII's latest filing finishes processing.